Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.medscape.org › sites › advancesClinical Advances in Clinical Perspectives on Cannabinoids ...

    Hace 4 días · This page features activities in diverse formats to increase your understanding of the basic science of cannabinoids; their use for rare epilepsy syndromes such as Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex; and relevant clinical data.

  2. www.osservatoriomalattierare.it › altre-malattie-cMalattia di Crohn, upadacitinib ottiene la rimborsabilità da ...

    Hace 3 días · Oltre alla malattia di Crohn, in Italia upadacitinib è rimborsato per il trattamento dei pazienti adulti con colite ulcerosa, artrite reumatoide, artrite psoriasica, spondilite anchilosante e dermatite atopica. Il farmaco ha mostrato risultati positivi nella risposta endoscopica, nel raggiungimento della remissione clinica e nella guarigione ...

  3. www.nippon-shinyaku.co.jp › news › newsプレスリリース・お知らせ │ 日本新薬

    Hace 3 días · 2022年. 2021年. 2020年. 日本新薬株式会社「プレスリリース・お知らせ」のページです。. 日本新薬のプレスリリース、お知らせを掲載しています。.

  4. www.healthyplace.com › other-info › psychiatricLamictal (Lamotrigine) Patient Information | HealthyPlace

    Hace 3 días · Lamictal is prescribed to control partial seizures in people with epilepsy. It is also used to control a serious form of epilepsy known as Lennox-Gastaut syndrome. Lamictal is used in combination with other antiepileptic medications or as a replacement for a medication such as Tegretol, Dilantin, phenobarbital, or Mysoline.

  5. www.findacode.com › icd-10-cm › g40G40.811 Lennox-Gastaut syndrome, not intractable, w stat epi ...

    4 de may. de 2024 · G40.811 - Lennox-Gastaut syndrome, not intractable, with status epilepticus The above description is abbreviated. This code description may also have Includes , Excludes , Notes, Guidelines, Examples and other information.

  6. Videos

    Ver todo

  7. www.osservatoriomalattierare.it › news › invaliditaRiforma disabilità: nove le provincie da cui partirà la ...

    Hace 3 días · Ecco le nove prescelte: Brescia, Catanzaro, Firenze, Forlì-Cesena, Frosinone, Perugia, Salerno, Sassari e Trieste. Sono nove province in cui, in base a un accordo tra il Ministero per le Disabilità, il Ministero della Salute e il Ministero del Lavoro e delle Politiche sociali, si avvierà a partire dal 1 gennaio 2025 la sperimentazione del nuovo sistema di riconoscimento dell'invalidità ...

  8. synapse.zhihuiya.com › drug › c5cc3b97d0344ffa94ce(Azetukalner) - 药物靶点：KCNQ (Kv7)_在研适应症：强直阵挛性癫痫，癫痫发作，癫痫部分性发作_专利...

    Hace 3 días · Azetukalner: 一种KCNQ (Kv7)调节剂药物，由Bausch Health Americas, Inc.公司最早进行研发，目前全球最高研发状态为临床3期，作用机制: KCNQ (Kv7)调节剂(KCNQ（Kv7）钾通道蛋白家族调节剂)，治疗领域: 神经系统疾病,其他疾病,内分泌与代谢疾病，在研适应症: 强直阵挛性癫痫,癫痫发作,癫痫部分性发作，在研机构 ...